Composition containing mulberry leaf extract as well as preparation method and application of composition

Through mixed fermentation and enzymatic lysis technology of bifungal strains, inhibitory, redness and anti-inflammatory components were extracted from mulberry leaves, solving the problem of insufficient preparation methods for plant extracts in the prior art, and realizing biological activity and Expanding application fields.

CN119033640AActive Publication Date: 2024-11-29广州博士派生物科技有限公司
View PDF 3 Cites 0 Cited by

Patent Information

Application Number
CN202411024919.4
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-29
Publication Date
2024-11-29
Estimated Expiration
2044-07-29

AI Technical Summary

Technical Problem

The lack of efficient preparation technology in the prior art that combines mixed fermentation and enzymatic decomposition of multiple bacteria, resulting in insufficient development of the biological activity and application fields of plant extracts.

Method used

Bacillus subtilis and oligotrophozoa rhizophila are used for mixed fermentation of bibacteria species. Combined with enzymatic lysis technology, mulberry leaf extracts are extracted from Asahi leaf, Bauhinia leaf and elliptical heliotropic mustard leaves, which are improved through fermentation and enzymatic lysis. Extraction rate and function of biologically active ingredients.

Benefits of technology

The anti-sensitivity, redness and anti-inflammatory effects of mulberry leaf extracts are achieved, the fermentation efficiency is improved, complex metabolites are produced, and the biological activity and application value of plant extracts are significantly improved.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004968263200000081
    Figure BDA0004968263200000081
  • Figure BDA0004968263200000091
    Figure BDA0004968263200000091
  • Figure BDA0004968263200000092
    Figure BDA0004968263200000092
Patent Text Reader

Abstract

The invention relates to a composition containing a mulberry leaf extract and a preparation method and application thereof, and belongs to the field of cosmetics, the composition is prepared from the mulberry leaf extract, a purple bergenia root extract and a plant bacterium fermentation product, and the plant bacterium fermentation product is prepared from angelica keiskei leaves, Chinese redbud leaves and rabdosia ellipsoides leaves. The fermentation strains are bacillus subtilis and stenotrophomonas rhizophila, and the fermentation mode is mixed fermentation; the composition containing the mulberry leaf extract has the effects of inhibiting allergy, removing redness, resisting inflammation and the like.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the field of cosmetics, and particularly relates to a composition containing mulberry leaf extract, and a preparation method and application thereof. Background Art

[0002] Plant extracts are popular because of their natural origin and diverse bioactive ingredients. These extracts usually contain antioxidants, anti-inflammatory agents, antibacterial agents, and a variety of ingredients that are beneficial to skin and body health. With the advancement of science and technology, researchers continue to explore and develop new extraction and processing technologies to improve the bioactivity and utilization of plant extracts.

[0003] As an advanced biotransformation method, fermentation technology has been widely used in the field of plant extract processing in recent years. This technology uses the metabolic activity of microorganisms to perform deep fermentation on raw materials, which can not only improve the extraction rate of active ingredients, but also produce new bioactive substances through the metabolism of microorganisms, thereby giving plant extracts a wider range of functions and higher value.

[0004] However, the research on the preparation methods and application effects of these plant extracts in the market is still insufficient, especially the lack of efficient preparation processes that combine mixed fermentation of multiple bacteria with enzymatic hydrolysis technology. Therefore, the development of a plant extraction technology based on bacterial fermentation and enzymatic hydrolysis technology is of great significance for improving the biological activity of plant extracts and broadening their application areas. Summary of the invention

[0005] The present invention provides a composition containing mulberry leaf extract, a preparation method and application thereof, and obtains a natural ingredient with the effects of suppressing allergy, removing redness, and resisting inflammation by extracting from plants.

[0006] In order to achieve the above object, the present invention adopts the following technical solutions:

[0007] In a first aspect, the present invention provides a method for preparing a plant bacterial fermentation extract, the specific steps of which are as follows:

[0008] S1: Take leaves of Angelica keiskei, leaves of Bauhinia chinensis, and leaves of Heliotropium ovata, grind them, put them in a container, add deionized water, and mix them evenly to obtain T1;

[0009] S2: using cellulase and pectinase to enzymolyze the T1 mixture to obtain enzymolysis product Y1;

[0010] S3: adding glucose fermentation medium to Y1, mixing evenly to obtain Y2, and sterilizing for later use;

[0011] S4: Mix Bacillus subtilis and Rhizotrophic Mononas to ferment Y2, and after the fermentation is completed, inactivate at high temperature and filter to obtain fermentation liquid X1;

[0012] S5: freeze-drying the fermentation liquid X1 to obtain a fermentation product X2.

[0013] The mass ratio of Angelica keiskei leaves, Bauhinia leaves and Heliotropium elliptica leaves in S1 is 1:2-3:1-2; the mass ratio of the total mass of Angelica keiskei leaves, Bauhinia leaves and Heliotropium elliptica leaves to water is 1:800-1000.

[0014] The mass fraction ratio of cellulase to pectinase in S2 is 1:1.5-1.8; the total dosage of cellulase and pectinase is 1-1.5wt% of T1; the cellulase activity is ≥10000U / g, and the pectinase activity is ≥10000U / g; and the enzymolysis time is 4-6h.

[0015] The amount of glucose fermentation medium in S3 is 30-35 wt % of Y1.

[0016] The mass ratio of Bacillus subtilis and Stenotrophomonas rhizophila in S4 is 1:0.8-1.2; the total dosage of Bacillus subtilis and Stenotrophomonas rhizophila is 10-12wt% of Y2; the fermentation time is 10-12h; the fermentation starting temperature is 15-20°C, the fermentation pH is 5.5-6.5; and the fermentation oxygen content is 8-12%.

[0017] In a second aspect, the present invention provides a composition containing mulberry leaf extract, wherein the composition comprises the following raw materials in parts by weight:

[0018] 15-18 parts of mulberry leaf extract;

[0019] 6-8 parts of Bergenia lingua root extract;

[0020] 2-5 parts of plant bacterial fermentation products.

[0021] In a third aspect, the present invention provides a skin external preparation, the raw material composition of which is as follows:

[0022] The composition contains 0.1-5wt% of mulberry leaf extract, 1-3wt% of honey, 1-2wt% of sodium hyaluronate, 0.1-0.3wt% of ceramide NP, and the balance is deionized water.

[0023] A skin external preparation, the preparation steps of which are as follows:

[0024] T1: Mix honey and sodium hyaluronate evenly, add to deionized water at 30-45°C, and stir until completely dissolved to obtain mixed solution Q1;

[0025] T2: Add ceramide NP and a composition containing mulberry leaf extract to Q1, stir, and homogenize to obtain a mixed solution Q2.

[0026] In the present invention, the plant raw material is firstly enzymatically hydrolyzed, and then fermented by bacteria, that is, Bacillus subtilis and Rhizotrophic Mononas are used to perform double-strain mixed fermentation on the enzymatically hydrolyzed plant raw material, and different strains with different metabolic capabilities are used in combination to complete the complex metabolism that is difficult to be completed by a single bacteria.

[0027] Compared with the prior art, the beneficial effects of the present invention are as follows: the present invention innovatively uses tomorrow leaf leaves, bauhinia leaves, and elliptically-leaved heliotropium leaves as fermentation substrates, and uses dual bacteria for fermentation. Different microorganisms have different metabolic pathways and production capacities during the fermentation process. During the dual bacterial mixed fermentation process, the two microorganisms cooperate with each other and jointly complete a metabolic pathway that is difficult to complete by a single strain of bacteria, thereby improving the fermentation efficiency and bringing unexpected results. Secondly, during the dual bacterial mixed fermentation process, the synergistic effect of the two will produce more complex metabolites, thereby achieving better anti-allergic, anti-redness, and anti-inflammatory effects under non-fermentation conditions. DETAILED DESCRIPTION

[0028] In order to better understand the present invention, the present invention is further described below in conjunction with specific examples, wherein the terms used in the examples are for describing specific embodiments and do not constitute limitations on the scope of protection of the present invention.

[0029] The experimental methods in the following examples without specifying specific conditions are usually carried out under conventional conditions or conditions recommended by the manufacturer. Unless otherwise specified, the calculation is based on mass percentage and mass fraction.

[0030] Some raw materials and their sources are as follows:

[0031] Mulberry leaf extract: purchased from Hunan Langlin Biological Resources Co., Ltd., product number: NAT-150;

[0032] Bergenia lingua root extract: purchased from Xi'an Ruierli Bioengineering Co., Ltd., product number: REL36578;

[0033] Angelica keiskei leaves: purchased from Shaanxi New Horizon Biotechnology Co., Ltd.;

[0034] Cercis chinensis leaves: purchased from Shaanxi New Horizon Biotechnology Co., Ltd.;

[0035] Heliotropium ellipticum leaves: purchased from Shaanxi New Horizon Biotechnology Co., Ltd.;

[0036] Bacillus subtilis: purchased from Ningbo Mingzhou Biotechnology Co., Ltd., catalog number: TS276952;

[0037] Stenotrophomonas rhizophila: purchased from Ningbo Testo Biotechnology Co., Ltd., catalog number: TS277074;

[0038] Stenotrophomonas acidaminiphila: purchased from Ningbo Testo Biotechnology Co., Ltd., catalog number: TS326523.

[0039] The present application provides a method for preparing a plant bacterial fermentation extract, the specific steps of which are as follows:

[0040] S1: Take Angelica keiskei leaves, Cercis chinensis leaves, and Heliotropium ovata leaves, crush them, put them in a container, add deionized water, and mix them evenly to obtain T1;

[0041] S2: using cellulase and pectinase to enzymolyze the T1 mixture to obtain enzymolysis product Y1;

[0042] S3: adding glucose fermentation medium to Y1, mixing evenly to obtain Y2, and sterilizing for later use;

[0043] S4: Mix Bacillus subtilis and Rhizotrophic Mononas to ferment Y2, and after the fermentation is completed, inactivate at high temperature and filter to obtain fermentation liquid X1;

[0044] S5: freeze-drying the fermentation liquid X1 to obtain a fermentation product X2.

[0045] The mass ratio of Angelica keiskei leaves, Bauhinia leaves and Heliotropium elliptica leaves in S1 is 1:2-3:1-2; the mass ratio of the total mass of Angelica keiskei leaves, Bauhinia leaves and Heliotropium elliptica leaves to deionized water is 1:800-1000.

[0046] The mass fraction ratio of cellulase to pectinase in S2 is 1:1.5-1.8; the total mass percentage of cellulase and pectinase accounts for 1-1.5% of T1; the enzymatic activity of cellulase is ≥10000U / g, and the enzymatic activity of pectinase is ≥10000U / g; and the enzymolysis time is 4-6h.

[0047] The mass fraction ratio of Bacillus subtilis and Stenotrophomonas rhizophila in S3 is 1:0.8-1.2; the glucose fermentation medium accounts for 30-35% of the mass percentage of Y1; the total mass of Bacillus subtilis and Stenotrophomonas rhizophila accounts for 10-12% of the mass percentage of Y2; the fermentation time is 10-12h; the fermentation starting temperature is 35-38°C, the fermentation pH is 5.5-6.5; and the fermentation oxygen content is 8-12%.

[0048] Example 1: Following steps S1-S5, X2 is the final product; wherein the mass ratio of Angelica keiskei leaves, Bauhinia leaves, and Heliotropis elliptica leaves in S1 is 1:2:1; the mass ratio of the total mass of the Angelica keiskei leaves, Bauhinia leaves, and Heliotropis elliptica leaves to deionized water is 1:800; the mass ratio of cellulase to pectinase in S2 is 1:1.5; the total amount of the cellulase and pectinase is 1wt% of T1, and the cellulase Enzyme activity ≥ 10000U / g, pectinase activity ≥ 10000U / g; enzymolysis time 4h; the mass ratio of Bacillus subtilis and Stenotrophomonas rhizophila in S4 is 1:0.8; the amount of glucose fermentation medium is 30wt% of Y1; the total amount of Bacillus subtilis and Stenotrophomonas rhizophila is 10wt% of Y2; fermentation time 10h; fermentation starting temperature 20°C, fermentation pH 5.5; fermentation oxygen content 8%; X2 is the final product.

[0049] Example 2: Following steps S1-S4, X2 is the final product; wherein the mass fraction ratio of Angelica keiskei leaves, Bauhinia leaves, and Heliotropis elliptica leaves in S1 is 1:3:2; the total mass fraction ratio of Angelica keiskei leaves, Bauhinia leaves, and Heliotropis elliptica leaves to deionized water is 1:1000; the mass fraction ratio of cellulase to pectinase in S2 is 1:1.8; the total mass percentage of cellulase and pectinase accounts for 1.5% of T1, and the enzymatic activity of cellulase is ≥ 10000U / g, pectinase activity ≥10000U / g; enzymatic hydrolysis time 6h; the mass fraction ratio of Bacillus subtilis and Stenotrophomonas rhizophila is 1:1.2; the glucose fermentation medium accounts for 35% of the mass percentage of Y1; the total mass of Bacillus subtilis and Stenotrophomonas rhizophila accounts for 12% of the mass percentage of Y2; fermentation time 12h; fermentation starting temperature 15°C, fermentation pH 6.5; fermentation oxygen content 12%; X2 is the final product.

[0050] Example 3: Following steps S1-S4, X2 is the final product; wherein the mass fraction ratio of Angelica keiskei leaves, Bauhinia leaves, and Heliotropis elliptica leaves in S1 is 1:2.5:1.5; the total mass fraction ratio of Angelica keiskei leaves, Bauhinia leaves, and Heliotropis elliptica leaves to deionized water is 1:960; the mass fraction ratio of cellulase to pectinase in S2 is 1:1.6; the total mass percentage of cellulase and pectinase accounts for 1.25% of T1, and the cellulose The enzyme activity is ≥10000U / g, and the pectinase activity is ≥10000U / g; the enzymatic hydrolysis time is 5h; the mass fraction ratio of Bacillus subtilis and Stenotrophomonas rhizophila is 1:1; the glucose fermentation medium accounts for 33% of the mass percentage of Y1; the total mass of Bacillus subtilis and Stenotrophomonas rhizophila accounts for 11% of the mass percentage of Y2; the fermentation time is 11h; the fermentation starting temperature is 17°C, the fermentation pH is 6; the fermentation oxygen content is 10%; and X2 is the final product.

[0051] Comparative Example 1: The bacterial species in S4 was changed to use only Bacillus subtilis, and the remaining steps followed S1-S5 of Example 3, with X2 as the final product.

[0052] Comparative Example 2: The bacterial species in S4 was changed to use only Stenotrophomonas rhizophila, and the remaining steps followed S1-S5 of Example 3, with X2 as the final product.

[0053] Comparative Example 3: In S4, the rhizotrophic bacteria were replaced by acidophilic bacteria, and the remaining steps were the same as S1-S5 of Example 3, with X2 as the final product.

[0054] Comparative Example 4: The Angelica keissima leaves, Bauhinia leaves, and Heliotropium elliptica leaves in a mass fraction ratio of 1:2.5:1.5 in S1 were replaced with Angelica keissima leaves and Bauhinia leaves in a mass fraction ratio of 1:2.5, and the remaining steps followed S1-S5 of Example 3, with X2 as the final product.

[0055] Comparative Example 5: The Angelica keissima leaves, Bauhinia chinensis leaves, and Heliotropium ovata leaves in a mass fraction ratio of 1:2.5:1.5 in S2 were replaced with Angelica keissima leaves and Heliotropium ovata leaves in a mass fraction ratio of 1:1.5; the remaining steps followed Example 3S1-S4, with X2 as the final product.

[0056] Comparative Example 6: The Angelica keissima leaves, Bauhinia leaves, and Heliotropium ovata leaves in a mass fraction ratio of 1:2.5:1.5 in S2 are replaced with Angelica keissima leaves, Bauhinia leaves, and Heliotropium ovata in a mass fraction ratio of 1:2.5:1.5; the remaining steps follow Example 3S1-S4, and X2 is the final product.

[0057] A composition containing mulberry leaf extract, wherein the mass fractions of the components are as follows:

[0058] Example 4: 15 parts of mulberry leaf extract; 6 parts of Bergenia lingua root extract; 5 parts of plant bacterial fermentation product (Example 3, X2).

[0059] Example 5: 18 parts of mulberry leaf extract; 8 parts of Bergenia lingua root extract; 2 parts of plant bacterial fermentation product (Example 3, X2).

[0060] Example 6: 16 parts of mulberry leaf extract; 7 parts of Bergenia oleracea root extract; 4 parts of plant bacterial fermentation product (Example 3, X2).

[0061] Example 7: 16 parts of mulberry leaf extract; 7 parts of Bergenia oleracea root extract; 4 parts of plant bacterial fermentation product (Example 1, X2).

[0062] Example 8: 16 parts of mulberry leaf extract; 7 parts of Bergenia oleracea root extract; 4 parts of plant bacterial fermentation product (Example 2, X2).

[0063] Comparative Example 7: 16 parts of mulberry leaf extract; 7 parts of Bergenia oleracea root extract; 4 parts of plant bacterial fermentation product (Comparative Example 1, X2).

[0064] Comparative Example 8: 16 parts of mulberry leaf extract; 7 parts of Bergenia lingua root extract; 4 parts of plant bacterial fermentation product (Comparative Example 2, X2).

[0065] Comparative Example 9: 16 parts of mulberry leaf extract; 7 parts of Bergenia oleracea root extract; 4 parts of plant bacterial fermentation product (Comparative Example 3, X2).

[0066] Comparative Example 10: 16 parts of mulberry leaf extract; 7 parts of Bergenia lingua root extract; 4 parts of plant bacterial fermentation product (Comparative Example 4, X2).

[0067] Comparative Example 11: 16 parts of mulberry leaf extract; 7 parts of Bergenia lingua root extract; 4 parts of plant bacterial fermentation product (Comparative Example 5, X2).

[0068] Comparative Example 12: 16 parts of mulberry leaf extract; 7 parts of Bergenia lingua root extract; 4 parts of plant bacterial fermentation product (Comparative Example 6, X2).

[0069] Comparative Example 13: 0 parts of mulberry leaf extract; 7 parts of Bergenia oleracea root extract; 4 parts of plant bacterial fermentation product (Example 3, X2).

[0070] Comparative Example 14: 16 parts of mulberry leaf extract; 0 parts of Bergenia lingua root extract; 4 parts of plant bacterial fermentation product (Example 3, X2).

[0071] Comparative Example 15: 16 parts of mulberry leaf extract; 7 parts of Bergenia lingua root extract; 0 parts of plant bacterial fermentation product (Example 3, X2).

[0072] A preparation method of a skin retention agent is as follows:

[0073] T1: Mix honey and sodium hyaluronate evenly, add to 30-45℃ deionized water, and stir until completely dissolved to obtain mixed solution Q1;

[0074] T2: Add ceramide NP and a composition containing mulberry leaf extract to Q1, stir, and homogenize to obtain a mixed solution Q2.

[0075] The dosage of the composition containing mulberry leaf extract is 0.1-5wt%; the dosage of honey is 1-3wt%; the dosage of sodium hyaluronate is 1-2wt%; the dosage of ceramide NP is 0.1-0.3wt%; and the balance is made up of deionized water.

[0076] Example 9: The skin topical preparation is prepared according to the above steps T1-T2, wherein the composition containing mulberry leaf extract uses the composition in Example 6; the amount of the composition containing mulberry leaf extract in the skin topical preparation is 3wt%, the amount of honey is 2wt%; the amount of sodium hyaluronate is 1.5wt%, the amount of ceramide NP is 0.2wt%, and the balance is made up with deionized water.

[0077] Example 10: The skin topical preparation is prepared according to the above steps T1-T2, wherein the composition containing mulberry leaf extract uses the composition in Example 6; the amount of the composition containing mulberry leaf extract in the skin topical preparation is 0.1wt%, the amount of honey is 2wt%; the amount of sodium hyaluronate is 1.5wt%, the amount of ceramide NP is 0.2wt%, and the balance is made up with deionized water.

[0078] Example 11: The skin topical preparation is prepared according to steps T1-T2 above, wherein the composition containing mulberry leaf extract uses the composition in Example 6; the amount of the composition containing mulberry leaf extract in the skin topical preparation is 5wt%, the amount of honey is 2wt%; the amount of sodium hyaluronate is 1.5wt%, the amount of ceramide NP is 0.2wt%, and the balance is made up with deionized water.

[0079] Comparative Example 15: The skin topical preparation was prepared according to the above steps T1-T2, wherein the composition containing mulberry leaf extract used was the composition in Example 6; the amount of the composition containing mulberry leaf extract in the skin topical preparation was 10wt%, and the amount of honey was 2wt%; the amount of sodium hyaluronate was 1.5wt%, the amount of ceramide NP was 0.2wt%, and the balance was made up with deionized water.

[0080] Safety Test

[0081] With reference to the 2015 Technical Specification for Safety of Cosmetics, the compositions of Examples 4-8 were prepared by referring to the method of Example 9 T1-T2 for skin retention preparations to conduct a cosmetic irritation evaluation. The test method was a skin patch test, and 50 randomly distributed people aged 16-65 years were tested.

[0082] Test method: Put the test substance into the patch tester, the dosage is 0.020-0.025g, cover the patch tester with the test substance on the back or forearm of the subject with non-irritating cloth-based tape, and gently press it with the palm to make it evenly adhere to the skin surface for 24 hours. After removing the test patch tester, observe the skin reaction after the indentation disappears 30 minutes later. If the result is negative, observe again 24 hours and 48 hours after the patch test.

[0083] Evaluation criteria:

[0084] Grade 0: negative reaction;

[0085] Grade 1: Suspicious reaction, only slight erythema;

[0086] Grade 2: weak positive reaction, erythema, infiltration, edema, and papules may be present;

[0087] Grade 3: Strong positive reaction, erythema, infiltration, edema, papules, and the reaction may extend beyond the test area;

[0088] Grade 4: Very strong positive reaction, obvious erythema, severe infiltration, edema, confluent herpes, and the reaction exceeds the test area.

[0089] Test results: Skin reactions were negative in all subjects.

[0090] The above test results show that the skin retention agent prepared by the composition containing mulberry leaf extract provided by the present invention is mild and non-irritating to the skin and safe to use.

[0091] Composition anti-inflammatory test

[0092] The compositions of Examples 4-8 and Comparative Examples 7-15 were evaluated for skin allergy inhibition using a xylene-induced mouse ear swelling model.

[0093] Experimental animals: Kunming mice, SPF grade, Guangzhou Ruige Biotechnology Co., Ltd., license number SCXK (Guangdong) 2023-0059, weighing 18-20 g, half male and half female, a total of 160 mice, randomly divided into 16 groups, 10 mice in each group.

[0094] Blank group: 0.05 ml of xylene was evenly applied to the right ears of mice. After 1.5 hours, the mice were killed by cervical dislocation, and the left and right ears were pierced and weighed.

[0095] Positive group: 0.05 ml of xylene was evenly applied to the right ear of the mice. After 30 minutes, 0.1 g of Piyanping was applied to the right ear. After 1 hour, the mice were killed by cervical dislocation, and the left and right ears were pierced and weighed.

[0096] Experimental group: 0.05 ml of xylene was evenly applied to the right ear of mice. After 30 minutes, 0.1 g of Example 4-8 and Comparative Example 7-15 were applied to the right ear. After 1 hour, the mice were killed by cervical dislocation, and the left and right ears were punched and weighed.

[0097] Test method: Xylene applied to the ears of mice can cause local tissue inflammation, release inflammatory substances, and cause acute exudative edema of the ears. The mice were randomly divided into 16 groups, namely, blank group, positive group and experimental group, with ten mice in each group. 0.05ml of xylene was evenly applied to the right ears of mice in each group. After 30 minutes, except for the blank group, the corresponding drugs were applied to the right ears of mice in each group, 0.1g per group, and the drugs were used for 60 minutes. The mice were killed by cervical dislocation, and the ear pieces of the same part of the ears of the mice were punched with a 7mm puncher, and the weights were weighed. The difference in the weight of the ear pieces of the two ears was the swelling degree, and the average swelling degree of each group was calculated. The results are shown in Table 1.

[0098] Table 1

[0099]

[0100]

[0101] According to the results of Examples 5-9 in Table 1, the compositions provided by the embodiments of the present invention have good anti-inflammatory effects, especially the effect of Example 6 is good, indicating that the composition has the best anti-inflammatory effect.

[0102] By comparing the results of Example 6 with Comparative Examples 7-9 and Comparative Examples 10-12, it can be seen that the use of the specific fermentation extraction method and the specific extraction raw materials of the present invention can significantly improve the anti-inflammatory effect of the composition.

[0103] Comparing the results of Example 6 with Comparative Examples 12-15, it can be seen that the use of the specific combination provided by the present invention can effectively enhance the anti-inflammatory effect.

[0104] Histamine release rate assay

[0105] Mast cells (HMC-1) were adjusted to contain about 5×10 4 1 mg of Example 6 and Comparative Examples 7-15 were added to each group, placed in a 37°C, 5% CO2 incubator for 20 minutes, and immediately added with Compound 48 / 80 (0.5 μg / ml) after removal, and placed in a 3% CO2 incubator at 7°C for 10 minutes. The reaction was immediately terminated by placing in an ice water bath for 5 minutes. The drug was replaced with PBS in the model control group, and the normal control group was a group not treated with drug and Compound 48 / 80. Then, the cell culture supernatant of the drug group, model control group, and normal control group was tested by fluorescence determination, and the cell supernatant after lysis was tested.

[0106] Table 2

[0107]

[0108]

[0109] According to the results of comparing Example 6 with Comparative Examples 7-12 in Table 2, the use of the fermentation process of the present invention and the specific fermentation raw materials and strains can significantly improve the efficacy of the composition in inhibiting the release of histamine.

[0110] Comparing the results of Example 6 with Comparative Examples 13-15, it can be seen that the use of the specific combination of raw materials provided by the present invention can effectively enhance the efficacy of the composition in inhibiting the release of histamine.

[0111] Human body 30s instant soothing effect test

[0112] Volunteer selection criteria: a) healthy volunteers aged 18 to 60 years old; b) subjects without skin lesions / dermatitis or other factors that affect measurement in the test area; c) those with sensitive and dry faces; d) those with positive lactic acid stinging test results.

[0113] The number of volunteers is guaranteed to be more than 30, and the subjects should mainly engage in indoor activities to avoid long-term exposure to light and high temperature or cold environments.

[0114] 40 volunteers aged 22-55 with sensitive facial skin (lactic acid stinging test score on both sides of the nose wing ≥ 3 points) and dry East Asian skin were selected. A sample group and a blank group (i.e., a model control group: no sample was applied) were set up, and the test areas were randomly distributed on the left and right faces of the volunteers. After using the skin resident agent of the present invention for 30 seconds, the red image was collected by the skin facial image analyzer VISIA7, and the skin redness a* value was analyzed by Image-ProPlus (IPP) analysis software to evaluate its redness removal and soothing effects. The laboratory temperature was 21±1°C and the relative humidity was 50%±10%.

[0115] The experiment adopted the self-before and after control method and the blank group control method. The test cycle was 30s, and the skin image collection times were 2 times, 0s and 30s respectively. The sample group and the blank group (i.e. the model control group: no sample was applied) were set up, and the test area was randomly distributed on the left and right faces of the volunteers. The sample was applied at a dosage of 0.25g / half face. Qualified subjects were selected according to the requirements. When the volunteers visited, they signed the volunteer informed consent form, collected skin images and questionnaire data after using the product for 30s. When visiting, after washing the face with the designated cleanser, sit quietly in the test environment for about 20-30 minutes. After the sitting, the test began.

[0116] With the help of facial image analyzer VISIA7( Company, USA), the instrument uses 3 different light sources to capture facial images and can intuitively observe changes in facial skin conditions.

[0117] The red image a* value was analyzed using Image-ProPlus software.

[0118] Skin redness a* value: The a* value represents the redness of the skin. An increase in the a* value indicates an increase in the vascular reactivity of the skin.

[0119] The data were analyzed using SPSS19.0 data analysis software.

[0120] Table 3

[0121]

[0122] From the analysis of the results in Table 3: Comparing Examples 9-11 and Comparative Example 15, the results show that the skin redness a* of Examples 9-11 is reduced, and the degree of reduction is the highest in Example 11, indicating that the skin resident agent prepared using the composition of the present invention has a skin redness-removing and soothing effect, which does not show a linear trend with the amount of addition.

[0123] Comparative Example 11 and Comparative Example 15 show that too high an addition amount of the composition cannot significantly reduce the average value of skin redness, and the addition amount defined in the present invention can maximize the reduction of the skin redness a* value by the composition.

[0124] The embodiments described above are part of the embodiments of the present application, rather than all of the embodiments. The detailed description of the embodiments of the present application is not intended to limit the scope of the present application for protection, but merely represents the selected embodiments of the present application. Based on the embodiments in the present application, all other embodiments obtained by those skilled in the art without making creative work are within the scope of protection of the present application.

Claims

1. A composition containing mulberry leaf extract, characterized in that: Contains the following raw materials in parts by weight: 15-18 parts of mulberry leaf extract; 6-8 parts of Bergenia lingua root extract; 2-5 parts of plant bacterial fermentation products. The raw materials of the plant bacterial fermentation product are Angelica keiskei leaves, Bauhinia leaves, and Heliotropis ovata leaves, the mass ratio of the Angelica keiskei leaves, Bauhinia leaves, and Heliotropis ovata leaves is 1:2-3:1-2, and the extraction process of the plant bacterial fermentation product is enzymatic hydrolysis followed by bacterial fermentation. The specific preparation steps of the plant bacterial fermentation product are as follows: S1: Take Angelica keiskei leaves, Cercis chinensis leaves, and Heliotropium ovata leaves, grind them, put them in a container, add deionized water, and mix them evenly to obtain T1; S2: using cellulase and pectinase to enzymolyze the T1 mixture to obtain enzymolysis product Y1; S3: adding glucose fermentation medium to Y1, mixing evenly to obtain Y2, and sterilizing for later use; S4: taking Bacillus subtilis and Stenotrophomonas rhizophila to mix and ferment Y2, and after the fermentation is completed, inactivating at high temperature and filtering to obtain fermentation liquid X1; S5: freeze-drying the fermentation liquid X1 to obtain a fermentation product X2. The mass ratio of Angelica keiskei leaves, Bauhinia leaves and Heliotropium elliptica leaves in S1 is 1:2-3:1-2; the mass ratio of the total mass of Angelica keiskei leaves, Bauhinia leaves and Heliotropium elliptica leaves to water is 1:800-1000. The mass ratio of cellulase to pectinase in S2 is 1:1.5-1.8, the total dosage of cellulase and pectinase is 1-1.5wt% of T1, the cellulase activity is ≥10000U / g, and the pectinase activity is ≥10000U / g. The amount of glucose fermentation medium in S3 is 30-35 wt % of Y1. The mass ratio of Bacillus subtilis and Stenotrophomonas rhizophila in S4 is 1:0.8-1.2; the total mass of Bacillus subtilis and Stenotrophomonas rhizophila accounts for 10-12wt% of Y2. In the S2, the enzymatic hydrolysis time is 4-6 hours. In S4, the fermentation time is 10-12 hours, the fermentation starting temperature is 35-38° C., the fermentation pH is 5.5-6.5, and the fermentation oxygen content is 8-12%.

2. A skin external preparation, characterized in that: The composition comprising 0.1-5wt% of the mulberry leaf extract according to claim 1.

Citation Information

Patent Citations

  • Cacumen biotae fermentation product for scalp care, oil control and dandruff removal as well as preparation method and application of Cacumen biotae fermentation product

    CN117511827A

  • Plant fermentation anti-allergy agent as well as preparation method and application thereof

    CN118045018A

  • Cometics and makeup method

    WO2003015723A1